vTv Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover vTv Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $35.5, which forecasts a 144.15% increase in the stock price over the next year. The lowest target is $35 and the highest is $36.

Price Target: $35.5 (+144.15%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$35	$35.5	$36	$36
Change	+140.72%	+144.15%	+147.59%	+147.59%

* Price targets were last updated on Apr 9, 2025.

Analyst Ratings

The average analyst rating for vTv Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	1	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $36	Strong Buy	Initiates	$36	+147.59%	Apr 9, 2025
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $35	Strong Buy	Initiates	$35	+140.72%	Dec 9, 2024
Vernon Bernardino HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $240	Strong Buy	Reiterates	$240	+1,550.62%	Mar 7, 2023
Carl Byrnes Northland Capital Markets	Northland Capital Markets	Buy Maintains $60 → $80	Buy	Maintains	$60 → $80	+450.21%	Aug 17, 2022
Charles Duncan Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $200	Buy	Initiates	$200	+1,275.52%	Feb 18, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.02M

Revenue Next Year

n/a

EPS This Year

-4.05

from -3.20

EPS Next Year

-3.71

from -4.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	6.41M	4.01M	2.02M	-	1.02M	-	-	-
Revenue Growth	132.05%	-37.56%	-49.61%	-	-	-	-	-
EPS	-7.21	-8.29	-9.98	-9.71	-3.20	-4.05	-3.71	-3.87
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-4.17	-3.55	-3.51
Avg	-4.05	-3.71	-3.87
Low	-3.89	-3.82	-4.17

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.